A vial containing two peptides is not simply two single-compound vials combined. It introduces a set of documentation questions that a single-compound preparation never raises, and those questions are where most blend certificates fall short.
The extra questions a blend creates
- Is each component present, confirmed independently?
- What is the purity of each component, reported separately?
- What is the ratio between them, and how was it determined?
- Is the stated fill weight the total of both components, or the weight of each?
- Do the components resolve cleanly under the analytical method used?
The fourth is the one most often ambiguous on real certificates, and it is the one with the largest practical consequence. "10 mg" on a blend label can mean 10 mg total across both components or 10 mg of each. Those are materially different products at the same nominal size, and a certificate that does not disambiguate has left the most important quantity undefined.
Why identity must be confirmed per component
Mass spectrometry on a blend should show a signal consistent with each expected component, and the certificate should report the expected and observed mass for both. A single identity line covering "the blend" cannot establish that both are present, only that something was detected.
This matters because the two components of a blend are not equally difficult or expensive to produce. A certificate that confirms only one, or confirms neither individually, cannot rule out a preparation that is substantially one component.
Chromatographic resolution
For purity to be reported per component, the method has to separate them. If two peptides elute at similar retention times under the chosen gradient, their peaks overlap and neither purity figure is reliable. A properly documented blend either uses a method that resolves both, or says explicitly how the components were quantified.
This is a good reason to ask for the chromatogram on a blend specifically, more so than for a single compound. Two well-separated peaks with a quiet baseline is a visible answer to a question the summary figures cannot settle.
| On the certificate | What to look for |
|---|---|
| Product name | Both components named in full, matching the label. |
| Fill weight | Explicit statement of whether the figure is total or per component. |
| Identity | Expected and observed mass for each component separately. |
| Purity | A separate figure per component, each with the method named. |
| Ratio | The intended ratio and how it was verified. |
| Chromatogram | Two resolved peaks, ideally attached rather than described. |
Storage of blends
Storage conditions for a blend are governed by the more demanding of its components, not by an average. Where the documentation states a single condition for the preparation, that condition should reflect the stricter requirement. General storage principles apply as they do to any lyophilised reference material.
Frequently asked questions
What should a COA for a peptide blend show?
Both components named, identity confirmed separately for each with expected and observed mass, a purity figure per component with the method named, the intended ratio and how it was verified, and an explicit statement of whether the fill weight is total or per component.
Does 10 mg on a blend vial mean 10 mg of each component?
It depends entirely on the supplier's convention, which is why the certificate should state it explicitly. Total fill weight and per-component weight describe materially different products at the same nominal size.
Why does a blend need its chromatogram more than a single compound?
Because per-component purity is only meaningful if the analytical method actually separates the components. Two resolved peaks on the chromatogram demonstrate that separation. Summary figures alone cannot.